We offer four unique TAP devices that provide industry-leading snoring and sleep apnea treatment. Since no two patients are the same, your sleep device therapy should offer a range of options to suit your individual comfort and clinical needs. That’s why we have a trial appliance, custom appliances, and two CPAP mask options.
Quick-fit option like myTAP for immediate testing and relief—fitted in just 15 minutes.
Lab-crafted for personalized comfort, such as customTAP or dreamTAP, with metal-free materials and adjustable features.
Comfortable alternatives that interface with oral appliances for those preferring or needing CPAP support.
Hybrid solutions like TAP PAP CS, combining a custom oral device with CPAP for advanced cases and better compliance.
Oral Appliance Therapy (OAT) is a non-invasive treatment for obstructive sleep apnea (OSA) and snoring. It involves a custom-fitted device worn during sleep that gently repositions the lower jaw to keep the airway open. This improves airflow, reduces apnea events, and promotes better quality sleep—without the discomfort of masks, hoses, or machines like CPAP.
TAP devices are suitable for patients with mild to moderate obstructive sleep apnea, as well as those who cannot tolerate CPAP. They are also used in combination with CPAP in more severe cases. Providers can assess candidacy based on medical history, sleep study results, and patient preferences.
TAP devices feature a patented midline adjustment mechanism that offers greater comfort and precision. They are FDA-cleared, clinically validated through 60+ studies, and offer advanced options like hybrid therapy integration (TAP PAP). The customizable design allows providers to treat a broader range of patients effectively.
Yes. All custom TAP devices are PDAC-verified under code E0486, making them eligible for Medicare reimbursement and covered by most major insurance providers. Patients should consult with their provider or insurance company for specific coverage details.
TAP therapy is backed by more than 60 peer-reviewed clinical studies demonstrating its effectiveness in reducing apnea-hypopnea index (AHI), improving patient adherence, and enhancing quality of life. Its safety and efficacy are recognized by medical and dental professionals worldwide.